Product Information
Draflazine is a fluorescent derivative of the fatty acid arachidonic acid that binds to the phospholipase A2 receptor. This binding inhibits the release of arachidonic acid from membrane phospholipids and blocks the synthesis of prostaglandins. Draflazine has been shown to increase cardiac function after myocardial infarction, which may be due to its inhibition of reactive oxygen species production and activation of adenosine receptors. The drug also has antinociceptive properties, which have been shown in animal models using nociceptive tests such as tail-flick, hot-plate, and writhing tests. These effects are mediated by G protein-coupled adenosine receptors (A1, A2A).
Chemical properties
Technical inquiry about: 3D-NFA68129 Draflazine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.